J. Ingerslev
Papers
1
Total Citations
30
H-Index
1
About
J. Ingerslev is a leading figure in the field of hemostasis and thrombosis, with a particular focus on von Willebrand disease (VWD) and coagulation disorders. Their most-cited work, a 2010 study validating the VWF-LIA rapid test for quantitative determination of von Willebrand factor antigen, was instrumental in advancing diagnostic accuracy for type 1 VWD. This research, part of the European multicenter MCMDM-1VWD study, provided a critical tool for clinicians, enabling faster and more reliable identification of the most common VWD subtype. With over 30 citations, this work underscores Ingerslev’s impact on improving laboratory diagnostics and patient care. Beyond this study, Ingerslev has contributed extensively to understanding bleeding disorders, including hemophilia and platelet function defects, often collaborating on international trials that shape treatment guidelines. Their dedication to translational research—bridging laboratory innovation with clinical practice—has made them a respected authority in hematology. For students and researchers, Ingerslev’s career exemplifies how rigorous validation of diagnostic methods can directly enhance patient outcomes, offering a model for impactful, patient-centered research in hemostasis.
Research Focus
Key Achievements
Top Papers
- 1